breast cancer
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: (1) aged 20 to 60 years old; (2) patients with confirmed breast willingness; (3) of the hollow needle biopsy, histopathologic diagnosis of invasive breast cancer; (4) in patients with normal liver and kidney function, blood routine; (5) receied radiation and chemotherapy, chemotherapy regimens for CEF or EC - T. (6) signed informed consent, and willing to cooperate to neoadjuvant therapy and postoperative treatment and follow-up, good adherence.
Exclusion criteria
Exclusion criteria: (1) have diabetes, hyperlipidemia, severe cardio-cerebrovascular disease, kidney disease patients. (2) do not accept our MDT provide postoperative chemoradiotherapy solution; (3). In addition to having breast surgery, issue of breast shape and postoperative rehabilitation, also accept other treatment; (4) breast cancer patients with distant metastases and proven; (5) patients with a history of other malignant tumor; (6) known for any drugs in the neoadjuvant therapy has a history of severe allergic; (7) and breast cancer during pregnancy and lactation Male breast cancer patients (8); (9) have poor patient compliance.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| recurrent rate; | — |
Secondary
| Measure | Time frame |
|---|---|
| metastasis rate; | — |
Countries
China
Contacts
The affiliated ninth poeple's hospital, Shanghai Jiaotong University